Patrick A. Broderick - Feb 1, 2022 Form 4 Insider Report for Intersect ENT, Inc. (XENT)

Role
EVP, GC & Corporate Secretary
Signature
/s/ Patrick A. Broderick
Stock symbol
XENT
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
4
Date filed
2/3/2022, 08:19 PM
Previous filing
Dec 3, 2021
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENT Common Stock Award $0 +25.9K +122.03% $0.00 47.1K Feb 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of February 1, 2022.
F2 Includes 41,999 Restricted stock units.